Patents by Inventor David C. Remy

David C. Remy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4031223
    Abstract: Cyproheptadine derivatives substituted with a trifluoromethylthio group in one of the benzo rings and certain derivatives thereof are potent antipsychotic agents, with a low propensity to induce extrapyramidal side effects experienced with most major tranquilizers, and platelet aggregation inhibitors useful as antithrombotic agents. The antipsychotic activity resides in the levorotatory enantiomer whereas both enantiomers are platelet aggregation inhibitors. The novel compounds are prepared by treatment of the corresponding iodo compound with trifluoromethylthiocopper formed from bis-(trifluoromethylthio)mercury and copper powder.
    Type: Grant
    Filed: December 22, 1975
    Date of Patent: June 21, 1977
    Assignee: Merck & Co., Inc.
    Inventor: David C. Remy
  • Patent number: 4031222
    Abstract: Cyproheptadine derivatives substituted with a trifluoromethylthio or trifluoromethylsulfonyl group in one of the benzo rings and having a hydroxyalkyl or cycloalkylalkyl group on the piperidine nitrogen are potent antipsychotic agents, with a low propensity to induce extrapyramidal side effects that are experienced with most major tranquilizers. The tranquilizing activity is predominantly in the levorotatory enantiomers, whereas the dextrorotatory enantiomers have anticholinergic activity. Each enantiomer is useful as a source of the other by racemization. The novel compounds are prepared by treatment of the corresponding iodo or bromo compound with bis(trifluoromethylthio)mercury and copper powder.
    Type: Grant
    Filed: December 22, 1975
    Date of Patent: June 21, 1977
    Assignee: Merck & Co., Inc.
    Inventor: David C. Remy
  • Patent number: 4022902
    Abstract: The N-oxide of 10,11-dihydro-3-carboxycyproheptadine is disclosed to have pharmaceutical utility as an appetite stimulant and as an anthihistaminic agent. Also disclosed are processes for the preparation of such compound; pharmaceutical compositions comprising such compound; and methods of treatment comprising administering such compound and compositions.
    Type: Grant
    Filed: August 29, 1975
    Date of Patent: May 10, 1977
    Assignee: Merck & Co., Inc.
    Inventor: David C. Remy
  • Patent number: 4021561
    Abstract: 1-Methyl-4-[2-(trifluoromethylthio)thioxanthen-9-ylidene]piperidine and the corresponding 2-trifluoromethylsulfonyl compound are antipsychotic agents. They are prepared by dehydration of the corresponding 9-hydroxy-9-piperidyl compounds.
    Type: Grant
    Filed: December 22, 1975
    Date of Patent: May 3, 1977
    Assignee: Merck & Co., Inc.
    Inventors: David C. Remy, Susan F. Britcher
  • Patent number: 4020169
    Abstract: Trifluoromethylthiocopper, formed in situ by the reaction of bis-(trifluoromethylthio)mercury with copper, reacts with aromatic bromides and iodides to give aryl trifluoromethyl sulfides.
    Type: Grant
    Filed: December 22, 1975
    Date of Patent: April 26, 1977
    Assignee: Merck & Co., Inc.
    Inventors: David C. Remy, Mark B. Freedman
  • Patent number: 3974285
    Abstract: 10,11-Furo and 10,11-bis-(hydroxyalkyl) derivatives of cyproheptadine are disclosed having anticholinergic activity but with diminished or eliminated antiserotonin and antihistamine activity. Also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds, and methods of treatment comprising administering such compounds and compositions.
    Type: Grant
    Filed: January 30, 1975
    Date of Patent: August 10, 1976
    Assignee: Merck & Co., Inc.
    Inventor: David C. Remy
  • Patent number: 3960974
    Abstract: This invention concerns 2,3,5,6-dibenzobicyclo-[5.1.0]octanes which may be substituted at the 4-position by either halogen, ketonic oxygen or hydroxyl. These compounds are prepared from 5H-dibenzo[a,d]cyclohepten-5-one by reaction with ethyl trichloroacetate in the presence of sodium methoxide to give 8,8-dichloro-2,3,5,6-dibenzobicyclo[5.1.0]octan-4-one which is reduced to the corresponding 4-hydroxy compound. The resulting 4-hydroxy compound is dehalogenated and converted to the corresponding 4-chloro or 4-keto compound. The 4-substituted compounds are useful in preparing other compounds of our invention.4-Dialkylaminopropylidenedibenzobicyclo[5.1.0]-octane compounds and 4-dialkylaminopropyldibenzobicyclo[5.1.0]octane compounds, useful as antidepressant agents, are prepared from, respectively, dibenzobicyclo[5.1.0]-octan-4-one by reaction with a dialkylaminopropyl Grignard reagent followed by dehydration of the resulting carbinol or by reaction of a 4-halo-2,3,5,6-dibenzobicyclo[5.1.
    Type: Grant
    Filed: January 14, 1975
    Date of Patent: June 1, 1976
    Assignee: Merck & Co., Inc.
    Inventors: Edward L. Engelhardt, David C. Remy
  • Patent number: 3957871
    Abstract: This application discloses methods of preparing styrylaralkylamines and phenylethynylaralkylamines. The reaction of an N-formyl iodo benzylamine with a metal phenylacetylide followed by reduction or hydrolysis produces the desired phenylethynyl benzylamine. The corresponding styrylaralkylamine is produced by a catalytic hydrogenation of the phenylethynyl benzylamine.
    Type: Grant
    Filed: February 7, 1975
    Date of Patent: May 18, 1976
    Assignee: Merck & Co., Inc.
    Inventor: David C. Remy